10x Genomics Total Revenue

10x Genomics (TXG) currently reports a total revenue of $620M as of June 2026. That compares with $640M in the prior-year period — down 4.3% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore 10x Genomics's total revenue history and peer comparisons.

10x Genomics's total revenue decreased from $640M to $620M — a 4.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

10x Genomics's total revenue of $620M is lower than the Healthcare sector average of $110B. That is roughly 99.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

10x Genomics reported $620M in total revenue as of June 2026. That compares with $640M in the prior-year period — down 4.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $620M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for 10x Genomics, and consider following TXG for alerts when major investors trade the stock.